Technical Analysis for CGC - Canopy Growth Corporation

Grade Last Price % Change Price Change
grade A 46.85 -4.21% -2.06
CGC closed down 4.21 percent on Friday, October 19, 2018, on 1.12 times normal volume. It was able to find support at its 50 day moving average.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Down
See historical CGC trend table...

Date Alert Name Type % Chg
Oct 19 20 DMA Resistance Bearish 0.00%
Oct 19 50 DMA Support Bullish 0.00%
Oct 19 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Oct 19 Multiple of Ten Bearish Other 0.00%
Oct 19 Down 3 Days in a Row Weakness 0.00%
Oct 19 Down 4 Days in a Row Weakness 0.00%
Oct 18 Fell Below 20 DMA Bearish -4.21%
Oct 18 Calm After Storm Range Contraction -4.21%
Oct 18 Multiple of Ten Bearish Other -4.21%
Oct 18 Inside Day Range Contraction -4.21%

Older signals for CGC ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Canopy Growth is a world-leading diversified cannabis and hemp company, offering distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms. From product and process innovation to market execution, Canopy Growth is driven by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time. Canopy Growth has established partnerships with leading sector names including cannabis icon Snoop Dogg, breeding legends DNA Genetics and Green House seeds, and Fortune 500 alcohol leader Constellation Brands, to name but a few. Canopy Growth operates eight cannabis production sites with over 2.4 million square feet of production capacity, including over 500,000 square feet of GMP-certified production space. The Company has operations in seven countries across four continents. The Company is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the public's understanding of cannabis, and through its partly owned subsidiary, Canopy Health Innovations, has devoted millions of dollars toward cutting edge, commercializable research and IP development. Through partly owned subsidiary Canopy Rivers Corporation, the Company is providing resources and investment to new market entrants and building a portfolio of stable investments in the sector. From our historic public listing to our continued international expansion, pride in advancing shareholder value through leadership is engrained in all we do at Canopy Growth.
Is CGC a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 59.25
52 Week Low 9.8445
Average Volume 15,467,620
200-Day Moving Average 31.0775
50-Day Moving Average 46.0988
20-Day Moving Average 49.762
10-Day Moving Average 50.028
Average True Range 4.1024
ADX 17.92
+DI 23.9982
-DI 21.5027
Chandelier Exit (Long, 3 ATRs ) 46.9428
Chandelier Exit (Short, 3 ATRs ) 57.2072
Upper Bollinger Band 54.8721
Lower Bollinger Band 44.6519
Percent B (%b) 0.22
BandWidth 20.538162
MACD Line 0.9194
MACD Signal Line 1.3724
MACD Histogram -0.453
Fundamentals Value
Market Cap 536.1 Thousand
Num Shares 11.4 Thousand
EPS 0.98
Price-to-Earnings (P/E) Ratio 47.90
Price-to-Sales 0.66
Price-to-Book 2.39
PEG Ratio 0.00
Dividend 0.96
Dividend Yield 2.05%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 55.52
Resistance 3 (R3) 56.01 53.61 54.08
Resistance 2 (R2) 53.61 51.40 53.37 53.59
Resistance 1 (R1) 50.23 50.04 49.03 49.74 53.11
Pivot Point 47.83 47.83 47.23 47.59 47.83
Support 1 (S1) 44.45 45.62 43.25 43.96 40.59
Support 2 (S2) 42.05 44.26 41.81 40.11
Support 3 (S3) 38.67 42.05 39.63
Support 4 (S4) 38.18